Breast Cancer Epidemiology

Cancer Research

Volumn 48, Issue 20, 1988, Pages 5615-5623

  Kelsey, Jennifer L ^a   Berkowitz, Gertrud S ^b  

^a Department of Medicine   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; HORMONE;

BREAST CANCER; CIGARETTE SMOKING; DIET; FEMALE; HUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ALCOHOL DRINKING; BEHAVIOR; BIOLOGY; BREAST CANCER; CANCER; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE METHODS--SIDE EFFECTS; DIETHYLSTILBESTROL; DISEASES; ENDOCRINE SYSTEM; ESTROGENS--SIDE EFFECTS; FAMILY PLANNING; HORMONES; INCIDENCE; LITERATURE REVIEW; MEASUREMENT; NEOPLASMS; ORAL CONTRACEPTIVES--SIDE EFFECTS; PHYSIOLOGY; REPRODUCTIVE CONTROL AGENTS; RESEARCH METHODOLOGY;

ADOLESCENT; ADULT; ALCOHOL DRINKING; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL; DIETARY FATS; DIETHYLSTILBESTROL; FEMALE; HUMAN; MAMMOGRAPHY; MENOPAUSE; MIDDLE AGE; RISK FACTORS; SMOKING;

EID: 0023766378     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (214)

1. Kelsey, J. L. A review of the epidemiology of human breast cancer. Epidemici. Rev., 1: 74-109. 1979.
2. Miller, A. B., and Bulbrook, R. D. UICC multidisciplinary project on breast cancer: The epidemiology, aetiology and prevention of breast cancer. Int. J. Cancer. 37: 173-177, 1986.
3. McTiernan, A., and Thomas, D. B. Evidence for a protective effect of lactation on risk of breast cancer in young women. Am. J. Epidemici., 124: 353-358, 1986.
4. Byers, T., Graham S., Rzeplea, T., and Marshall, J. Lactation and breast cancer. Am. J. Epidemiol., 121: 664-674, 1985.
5. Kelsey, J. L., Fischer, D. B., Holford, T. R., LiVolsi, V. A., Mostow, E. D., Goldenberg, I. S., and White, C. Exogenous estrogens and other factors in the epidemiology of breast cancer. J. Natl. Cancer Inst., 67: 327-333, 1981.
6. Choi, N. W., Howe, G. R., Miller, A. B., Matthews, V., Morgan, R. W., Munan, L., Burch, J. D., Feather, J., Jain, M., and Kelly, A. An epidemiologie study of breast cancer. Am. J. Epidemiol., 707: 510-521. 1978.
7. Pike, M. C., Henderson, B. E., Casagrande, J. T., Rosario, I., and Gray, G. E. Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br. J. Cancer. 43: 72-76, 1981.
8. Brinton, L. A., Hoover, R., and Fraumeni, J. F. Reproductive factors in the aetiology of breast cancer. Br. J. Cancer, 47: 757-762, 1983.
9. Salber, E. J., Trichopoulos, D., and MacMahon, B. Lactation and reproductive histories of breast cancer patients in Boston 1965-66. J. Natl. Cancer Inst., 43: 1013-1024, 1969.
10. Paffenbarger, R. S., Jr., Kampert, J. B., and Chang, H. G. Characteristics that predict risk of breast cancer before and after the menopause. Am. J. Epidemiol., 112: 258-268, 1980.
11. Helmrich, S. P., Shapiro, S., Rosenberg, L., Kaufman, D. W., Sione, D., Bain, C., Miettinen, O. S., Stolley, P. D., Rosenshein, N. B., Knapp, R. C., Leavitt, T., Schottenfeld, D., Engle, R. L., and Levy, M. Risk factors for breast cancer. Am. J. Epidemiol. 117: 35-45. 1983.
12. Kvale, G., and Heuch, I. A prospective study of reproductive factors and breast cancer. II. Age at first and last birth. Am. J. Epidemiol., 126: 842-850, 1987.
13. Kvale, G., Heuch, I., and Eide, G. E. A prospective study of reproductive factors and breast cancer. I. Parity. Am. J. Epidemiol., 126: 831-841, 1987.
14. Adami, H. O., Hansen, J., Jung, B., and Rimsten, A. J. Age at first birth, parity and risk of breast cancer in a Swedish population. Br. J. Cancer, 42: 651-658, 1980.
15. Seidman, H., Stellman, S. D., and Mushinski, M. H. A Different Perspective on Breast Cancer Risk Factors: Some Implications of the Non-attributable Risk. New York: American Cancer Society Professional Education Publication, 1983.
16. Baron, J. A. Smoking and estrogen-related disease. Am. J. Epidemiol., 119: 9-22, 1984.
17. Baron, J. A., Byers, T., Greenberg, E. R., Cummings, K. M., and Swanson, M. Cigarette smoking in women with cancers of the breast and reproductive organs. J. Natl. Cancer Inst., 77: 677-680, 1987.
18. O'Connell, D. L., Hulka, B. S., Chambless, L. E., Wilkinson, W. E., and Deubner, D. C. Cigarette smoking, alcohol consumption, and breast cancer risk. J. Natl. Cancer Inst., 78: 229-234, 1987.
19. Schechter, M. T., Miller, A. B., and Howe, G. R. Cigarette smoking and breast cancer: A case-control study of screening program participants. Am. J. Epidemiol., 121: 479-487, 1985.
20. Hiatt, R. A., and Fireman, B. H. Smoking, menopause, and breast cancer. J. Natl. Cancer Inst., 76: 833-838, 1986.
21. Rosenberg, L., Miller, D. R., Helmrich, S. P., Kaufman, D. W., Schottenfeld, D., Stolley, P. D., and Shapiro, S. Breast cancer and the consumption of coffee. Am. J. Epidemiol., 122: 391-399, 1985.
22. Lubin, F., Ron, E., Wax, Y., and Modan, B. Coffee and methylxanthines and breast cancer: A case-control study. J. Natl. Cancer Inst., 74: 569-573, 1985.
23. Jacobsen, B. K., Bjelke, E., Kvale, G., and Heuch, I. Coffee drinking, mortality, and cancer incidence: Results from a Norwegian prospective study. J. Natl. Cancer Inst., 76: 823-831, 1986.
24. LaVecchia, C. L., Talamini, R., Decarli, A., Franceschi, S., Parazzini, F., and Tognoni, G. Coffee consumption and the risk of breast cancer. Surgery, 100: 477-481, 1986.
25. Schairer, C., Brinton, L. A., and Hoover, R. N. Methylxanthines and breast cancer. Int. J. Cancer, 40: 469-473, 1987.
26. Minton, J. P., Foecking, M. K., Webster, D. J. T., and Matthews, R. H. Response of fibrocystic disease to caffeine withdrawal and correlation of cyclic nucleotides to breast disease. Am. J. Obstet. Gynecol., 135: 157-158, 1979.
27. Ernster, V. L., Mason, L., Goodson, W. H., Sickles, E. A., Sacks, S. T., Selvin, S., Dupuy, M. E., Hawkinson, J., and Hunt, T. K. Effects of caffeine free diet on benign breast disease: A randomized trial. Surgery, 91: 263-269, 1982.
28. Heyden, S., and Muhlbaier, L. H. Prospective study of “fibrocystic breast disease” and caffeine consumption. Surgery, 96: 479-483, 1984.
29. Lawson, D. H., Jick, H., and Rothman, K. J. Coffee and tea consumption and breast disease. Surgery, 90: 801-803, 1981.
30. Marshall, J., Graham, S., and Swanson, M. Caffeine consumption and benign breast disease: A case-control comparison. Am. J. Public Health, 72: 610-612, 1982.
31. Boyle, C. A., Berkowitz, G. S., LiVolsi, V. A., Ort, S., Merino, M. J., White, C., and Kelsey, J. L. Caffeine consumption and fibrocystic breast disease: A case-control epidemiologie study. J. Natl. Cancer Inst., 72: 1015-1019, 1984.
32. LaVecchia, C., Franceschi, S., Parazzini, F., Regallo, M., Decarli, A., Gallus, G., DiPietro, S., and Tognori, G. Benign breast disease and consumption of beverages containing methylxanthines. J. Natl. Cancer Inst., 74: 995-1000, 1985.
33. Lubin, F., Ron, E., Wax, Y., Black, M., Funaro, M., and Shitrit, A. A. casecontrol study of caffeine and methylxanthines in benign breast disease. JAMA, 253: 2388-2392, 1985.
34. Odenheimer, D. J., Zunzunegui, M. V., King, M. C., Shipler, C. P., and Friedman, G. D. Risk factors for benign breast disease: A case-control study of discordant twins. Am. J. Epidemiol., 120: 565-571, 1984.
35. Schairer, C., Brinton, L. A., and Hoover, R. N. Methylxanthines and benign breast disease. Am. J. Epidemiol., 124: 603-611, 1986.
36. Priestman, T. J., Priestman, S. G., and Bradshaw, C. Stress and breast cancer. Br. J. Cancer, 51: 493-498. 1985.
37. Stevens, R. G. Electric power use and breast cancer: A hypothesis. Am. J. Epidemiol, 125: 556-561, 1987.
38. Frisch, R. E., Wyshak, G., Albright, N. L., Albright, T. E., Schiff, L., Jones, K. P., Witschi, J., Shiang, E., Koff, E., and Marguglio, M. Lower prevalence of breast cancer and cancers of the reproductive system among former college athletes compared to nonathletes. Br. J. Cancer, 52: 885-891, 1985.
39. Bernstein, L., Ross, R. K., Lobo, R. A., Hanisch, R., Krailo, M. D., and Henderson, B. E. The effects of moderate physical activity on menstrual cycle patterns in adolescence: Implications for breast cancer prevention. Br. J. Cancer, 55: 681-685, 1987.
40. Ellison, P. T., and Lager, C. Moderate recreational running is associated with lowered salivary progesterone profiles in women. Am. J. Obstet. Gynecol., 154: 1000-1003, 1986.
41. Rosenberg, L., Slone, D., Shapiro, S., Kaufman, D. W., Helmrich, S. P., Miettinen, O. S., Stolley, P. D., Levy. M., Rosenshein, N. B., Schottenfeld, I '., and Engle, R. L. Breast cancer and alcoholic beverage consumption. Lancet, 1: 267-270, 1982.
42. Williams, R. G., and Horm, J. W. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: Interview study from the Third National Cancer Survey. J. Natl. Cancer Inst., 58: 525-547, 1977.
43. Paganini-Hill, A., and Ross, R. K. Breast cancer and alcohol consumption. Lancet 2: 626-627, 1983.
44. Webster, L. A., Layde, P. M., Wingo, P. A., Dry, H. W., and The Cancer and Steroid Hormone study Group. Alcohol consumption and risk of breast cancer. Lancet, 2: 724-726, 1983.
45. Hiatt, R. A., and Bawol, R. D. Alcoholic beverage consumption and breast cancer incidence. Am. J. Epidemici., 120: 676-683, 1984.
46. LaVecchia, C., Decarli, A., Franceschi, S., Pampallona, S., and Tognoni, G. Alcohol consumption and the risk of breast cancer in women. J. Natl. Cancer Inst., 75: 61-65, 1985.
47. Harvey, E. B., Schairer, C., Brinton, L. A., Hoover, R. N., and Fraumeni, J. F., Jr. Alcohol consumption and breast cancer. J. Natl. Cancer Inst., 78: 657-661, 1987.
48. Willen, W. C., Stampfer, M. J., Colditz, G. A., Rosner, B. A., Hennekens, C. H., and Speizer, F. E. Moderate alcohol consumption and the risk of breast cancer. N. Engl. J. Med., 316: 1174-1180, 1987.
49. Schatzkin, A., Jones, D. Y., Hoover, R. N., Taylor, P. R., Brinton, L. A., Ziegler, R. G., Harvey, E. B., Carter, C. L., Licitra, L. M., Dufour, M. C., and Larson, D. B. Alcohol consumption and breast cancer in the epidemiologie follow-up study of the first National Health and Nutrition Examination Survey. N. Engl. J. Med., 316: 1169-1173, 1987.
50. Rohan, T. E., and Bain, C. J. Diet in the etiology of breast cancer. Epidemiol. Rev., 9: 120-145, 1987.
51. Freund, G. Possible relationships of alcohol in membranes to cancer. Cancer Res., 39: 2899-2901, 1979.
52. Wickramasinghe, S. N., Gardner, B., and Barden, G. Cytotoxic protein molecules generated as a consequence of ethanol metabolism in vitro and in vivo. Lancet, 2: 823-826, 1986.
53. Swann, P. F., Coe, A. M., and Mace, R. Ethanol and dimethylnitrosamine and diethylnitrosamine metabolism and disposition in the rat: Possible relevance to the influence of ethanol on human cancer incidence. Carcinogenesis (Lond.), 5: 1337-1343, 1984.
54. Beral, V., and Colwell, L. Randomized trial of high doses of stilbestrol and ethisterone in pregnancy: Long-term follow-up of mothers. Br. Med. J., 281: 1098-1101, 1980.
55. Vessey, M. P., Fairweather, D. V. I., Norman-Smith, B., and Buckley, J. A randomized double-blind controlled trial of the value of stilbestrol therapy in pregnancy: Long-term follow-up of mothers and their offspring. Br. J. Obstet. Gynaecol., 30: 1007-1017, 1983.
56. Hadjimichael, O. C., Meigs, J. W., Faleier, F. W., Thompson, W. D., and Flannery, J. T. Cancer risk among women exposed to exogenous estrogens during pregnancy. J. Natl. Cancer Inst., 73: 831-834, 1984.
57. Greenberg, E. R., Barnes, A. B., Resseguie, L., Barrett, J. A., Bernside, S., Langer, L. L., Neff, R. K., Stevens, M., Young, R. H., and Colton, T. Breast cancer in mothers given diethylstilbestrol in pregnancy. N. Engl. J. Med., 311: 1393-1398, 1984.
58. Anderson, D. E. A genetic study of human breast cancer. J. Natl. Cancer Inst., 48: 1029-1034. 1972.
59. Bain, C., Speizer, F. E., Rosner, B., Belanger, C., and Hennekens, C. H. Family history of breast cancer as a risk indicator for the disease. Am. J. Epidemiol., 111: 301-308, 1980.
60. Anderson, D. E. Genetic study of breast cancer: Identification of a high risk group. Cancer (Phila.), 34: 1090-1097, 1974.
61. Anderson, D. E. Breast cancer in families. Cancer (Phila.), 40: 1855-1860, 1977.
62. Finney, G. G., Jr., Finney, G. G., Montague, A. C. W., Stonesifer, G. L., Jr., and Brown, C. C. Bilateral breast cancer, clinical and pathological review. Ann. Surg., 175: 635-646, 1972.
63. Ottman, R., Pike, M. C., King, M.-C., and Henderson, B. E. Practical guide for estimating risk for familial breast cancer. Lancet, 2: 556-558, 1983.
64. Anderson, D. E., and Badzioch, M. D. Risk of familial breast cancer. Cancer (Phila.), 56: 383-387. 1985.
65. Schwartz, A. G., King, M.-C., Belle, S. J. H., Salariano, W. A., and Swanson, G. M. Risk of breast cancer to relatives of young breast cancer patients. J. Natl. Cancer Inst., 75: 665-668, 1985.
66. Sattin, R. W., Rubin, G. L., Webster, L. A., Huezo, C. M., Wingo, P. A., Ory, H. W., and Layde, P. M., and the Cancer and Steroid Hormone Study Group. Family history and the risk of breast cancer. JAMA, 253: 1908-1913, 1985.
67. Ottman, R., Pike, M.-C., King, M. C., Casagrande, J. T., and Henderson, B. E. Familial breast cancer in a population-based series. Am. J. Epidemiol., 123: 15-21, 1986.
68. Lynch, H. T., and Krush, A. J. Genetic predictability in breast cancer risk. Arch. Surg., 103: 84-88, 1971.
69. Swift, M., Reitnauer, P. J., Morrell, D., and Chase, C. L. Breast and other cancers in families with ataxia-telangiectasia. N. Engl. J. Med., 316: 1289-1294. 1987.
70. King, M-C., Go, R. C. P., Elston, R. C. Lynch, H. T., and Petrakis, N. L. Allele increasing susceptibility to human breast cancer may be linked to the glutamate-pyruvate transaminase locus. Science (Wash. DC), 208: 406-408, 1980.
71. King, M-C., Go, R. C. P., Lynch, H. T., Elston, R. C., Terasaki, P. I., Petrakis, N. C., Rodgers, G. C., Lattanzio, D., and Bailey-Wilson, J. Genetic epidemiology of breast cancer and associated cancers in high-risk families. II. Linkage analysis. J. Natl. Cancer Inst., 71: 463-467, 1983.
72. Williams, W. R., and Anderson, D. E. Genetic epidemiology of breast cancer: Further clarification and a response to King and Elston. Genet. Epidemiol., 2: 170-176, 1985.
73. Hutchinson, W. B., Thomas, D. B., Hamlin, W. B., Roth, G. J., Petersen, A. V., and Williams, B. Risk of breast cancer in women with benign breast disease. J. Natl. Cancer Inst., 65: 13-20, 1980.
74. Haagensen, C. D. Diseases of the Breast, Ed. 2. Philadelphia: W. B. SaundersCo., 1971.
75. Haagensen, C. D. The relationship of gross cystic disease of the breast and carcinoma. Ann. Surg., 185: 375-376, 1977.
76. Kodlin, D., Winger, E. E., Morgenstern, N. L., and Chen, U. Chronic mastopathy and breast cancer. A follow-up study. Cancer, (Phila.), 39: 2603-2607, 1977.
77. Page, D. L., Vander Zwaag, R., Rogers, L. W., Williams, L. T., Walker, W. E., and Hartmann, W. H. Relation between component parts of fibro cystic disease complex and breast cancer. J. Natl. Cancer Inst., 61: 1055-1063, 1978.
78. Humphrey, L. J., and Swerdlow, M. A. Large duct epithelial hyperplasia and carcinoma of the breast. Arch. Surg., 97: 592-594, 1968.
79. Black, M. M., Barclay, T. H. C., Cutler, S. J., Hankey, B. F., and Asire, A. J. Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer. Cancer (Phila.), 29: 338-343, 1972.
80. Dupont, W. D., and Page, D. L. Risk factors for breast cancer in women with proliferative breast disease. N. Engl. J. Med., 312: 146-151. 1985.
81. Dupont, W. D., and Page, D. L. Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer. Am. J. Epidemiol., 725: 769-779, 1987.
82. Wolfe, J. N. Breast patterns as an index of risk for developing breast cancer. AJR, 126: 1130-1139, 1976.
83. Wolfe, J. N. Risk for breast cancer development determined by mammo graphie parenchymal pattern. Cancer (Phila.), 37: 2486-2492, 1976.
84. Wilkinson, E., Clopton, C., Gordonson, J., Green, R., Hill, A., and Pike, M. C. Mammographie parenchymal pattern and the risk of breast cancer. J. Natl. Cancer Inst., 59: 1397-1400, 1977.
85. Mendell, L., Rosenbloom, M., and Naimark, A. Are breast patterns a risk index for breast cancer? A reappraisal. AJR, 128: 547, 1977.
86. Krook, P. M., Cariile, T., Bush, W., and Hall, M. H. Mammographie parenchymal patterns as a risk indicator for prevalent and incident cancer. Cancer (Phila.), 41: 1093-1097, 1978.
87. Ernster, V. L., Sacks, S. T., Peterson, C. A., and Schweitzer, R. J. Mammographie parenchymal patterns and risk factors for breast cancer. Radiology, 134: 617-620, 1980.
88. Moskowitz, M., Gartside, P., and McLaughlin, C. Mammographie patterns as markers for high-risk benign breast disease and incident cancers. Radiology, 134: 293-295, 1980.
89. Gravelle, I. H., Bulstrode, R. D., Bulbrook, R. D., Wang, D. Y., Allen, D., and Hayward, J. C. A prospective study of mammographie parenchymal patterns and risk of breast cancer. Br. J. Radiol., 59: 487-491, 1986.
90. Brisson, J., Merletti, F., Sadowsky, N. L., Twaddle, J. A., Morrison, A. S., and Cole, P. Mammographie features of the breast and breast cancer risk. Am. J. Epidemiol., 115: 428-437, 1982.
91. DeWaard, F., Collette, H. J. A., Rombach, J. J., Baanders-Van Halewijn, E. A., and Honing, C. The DOM Project for the early detection of breast cancer, Utrecht, The Netherlands. J. Chronic Dis., 37: 1-44, 1984.
92. Cariile, T., Kopecky, K. J., Thompson, D. J., Whitehead, J. R., Gilbert, F. I., Present, A. J., Threatt, B. A., Krook, P., and Hadaway, E. Breast cancer prediction and the Wolfe classification of mammograms. JAMA, 254: 1050-1053, 1985.
93. Saftlas, A. F., and Szklo, M. Mammographie parenchymal patterns and breast cancer risk. Epidemiol. Rev., 9: 146-174, 1987.
94. Gravelle, I. H., Bulstrode, J. C., Wang, D. Y., Bulbrook, R. D., and Hayward, J. L. The relation between radiographie features and determinants of risk of breast cancer: Br. J. Radiol., 53: 107-113, 1980.
95. DeWaard, F., Romback, J. J., Collette, H. J. A., and Slotboom, B. Breast cancer risk associated with reproductive factors and breast parenchymal patterns. J. Natl. Cancer Inst., 72: 1277-1282, 1984.
96. Buchanan, J. B., Weisberg, B. F., Sandoz, J. P., Gray, L. A., Sr., and Bland, K. I. Selected prognostic variables for mammographie parenchymal patterns. Cancer (Phila.), 47: 2135-2137, 1981.
97. Brisson, J., Sadowsky, N. L., Twaddle, J. A., Morrison, A. S., Cole, P., and Merletti, F. The relation of mammographie features of the breast to breast cancer risk factors. Am. J. Epidemiol., 115: 438-443, 1982.
98. Bergkvist, L., Tabar, L., Bergstrom, R., and Adami, H.-O. Epidemiologie determinants of the mammographie parenchymal pattern: A population based study within a mammographie screening program. Am. J. Epidemiol., 126: 1075-1081, 1987.
99. Whitehead, J., Cariile, T., Kopecky, K. J., Thompson, D. J., Gilbert, F. I., Present, A. J., Threatt, B. A., Krook, P., and Hadaway, E. The relationship between Wolfe's classification of mammograms, accepted breast cancer risk factors, and the incidence of breast cancer. Am. J. Epidemiol., 122: 994-1006, 1985.
100. Brisson, J., Morrison, A. S., Kopans, D. B., Sadowsky, N. L., Kalisher, L., Twaddle, J. A., Meyer, J. E., Henschke, C. I., and Cole, P. Height and weight, mammographie features of breast tissue and breast cancer risk. Am. J. Epidemiol., 119: 371-381, 1984.
101. Gravelle, I. H., Bulstrode, J. C., Bulbrook, R. D., Hayward, J. L., and Wang, D. Y. The relation between radiologie patterns of the breast and body weight and height. Br. J. Radiol., 55: 23-25, 1982.
102. Tokunaga, M., Normal, J. E., Jr., Asano, M., Tokuoka, S., Ezaki, H., Nishimori, I., and Tsuji, Y. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74. J. Natl. Cancer Inst., 62: 1347-1359, 1979.
103. Land, C. E., Boice, J. D., Jr., Shore, R. E., Norman, J. E., and Tokunaga, M. Breast cancer risk from low-dose exposures to ionizing radiation: Results of parallel analysis of three exposed populations of women. J. Natl. Cancer Inst., 65: 353-376, 1980.
104. Boice, J. D., Jr., and Monson, R. R. Breast cancer in women after repeated fluoroscopic examinations of the chest. J. Nail. Cancer Inst., 59: 823-832, 1977.
105. Shore, R. E., Hempelmann, L. H., Kowaluk, E., Mansur, P. S., Pasternack, B. S. Albert, R. E., and Haughie, G. E. Breast neoplasms in women treated with X-rays for acute postpartum mastitis. J. Natl. Cancer Inst., 59: 813-822, 1977.
106. Boice, J. D., Jr., Land, C. E., Shore, R. E., Norman, J. E., and Tokunaga, M. Risk of breast cancer following low-dose radiation exposure. Radiology. 131: 589-597, 1979.
107. Land, C. E., and McGregor, D. H. Breast cancer incidence among atomic bomb survivors: Implication for radiobiologic risk at low doses. J. Natl. Cancer Inst., 62: 17-21, 1979.
108. Davis, F. G., Boice, J. D., Kelsey, J. L., and Monson, R. R. Cancer mortality after multiple fluoroscopic examinations of the chest. J. Natl. Cancer Inst., 78: 645-652, 1987.
109. Shore, R. E., Hildreth, N., Woodward, E., Dvoretsky, P., Hempelmann, L., and Pasternack, B. Breast cancer among women given X-ray therapy for acute post-partum mastitis. J. Natl. Cancer Inst., 77: 689-696, 1986.
110. Storm, H. H., Iversen, E., and Boice, J. D., Jr. Breast cancer following multiple chest fluoroscopies among tuberculosis patients: A case-control study in Denmark. Acta Radiol. Oncol., 25: 233-238, 1986.
111. McGregor, D. H., Land, C. F., Choi, K., Tokuoka, S., Liu, P. J., Wakabayashi, T., and Beebe, G. W. Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1969. J. Natl. Cancer Inst., 59: 799-811, 1977.
112. Boice, J. D., Jr., and Stone, B. J. Interaction between radiation and other breast cancer risk factors. In. Late Biological Effects of Ionizing Radiation. Vol., 1, pp. 231-249. Vienna: International Atomic Energy Agency, 1978.
113. Tokunaga, M., Land, C. E., Yamamoti, T., Asano, M., Tokuoka, S., Ezaki, H., and Nishimori, I. Breast cancer in Japanese A-bomb survivors. Lancet, 2: 924, 1982.
114. Hildreth, N. G., Shore, R. E., and Hempelmann, L. H. Risk of breast cancer among women receiving radiation treatment in infancy for thymic enlargement. Lancet, 2: 273, 1983.
115. Hildreth, N. G., Shore, R. E., and Hempelmann, L. H. Risk of extrathyroid tumors following radiation treatment in infancy for thymic enlargement. Radiat. Res., 102: 378-391, 1985.
116. Evans, J. S., Wennberg, J. E., and McNeil, B. J. The influence of diagnostic radiography on the incidence of breast cancer and leukemia. N. Engl. J. Med., 315: 810-815, 1986.
117. Shapiro, S. Evidence on screening for breast cancer from a randomized trial. Cancer (Phila.), 39: 2772-2782, 1977.
118. Verbeek, A. L. M., Hendriks, J. H. C. L., Holland, R., Mravunac, M., and Sturmans, F. Mammographie screening and breast cancer mortality: Age-specific effects in Nijmegen project, 1975-1982. Lancet, 1: 865-866, 1985.
119. Collette, H. J., Day, N. E., Rombach, J. J., and DeWaard, F. Evaluation of screening for breast cancer in a non-randomized study (the Dom project) by means of a case-control study. Lancet, 1: 1224-1226, 1984.
120. Tabar, L., Gad, A., Holmberg, L. H., Ljungquist, U., Faberberg, C. J. G., Baldetorp, L., Grontoft, O., Lundstrom, B., Manson, J. C., Eklund, G., Day, N. E., and Pettersson, F. Reduction in mortality from breast cancer after mass screening with mammography. Lancet, 1: 829-832, 1985.
121. Palli, D., Rosselli Del Turco, M., Buiatti, E., Carli, S., Ciano, S., Toscani, L., and Maltoni, G. A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int. J. Cancer, 38: 501-504, 1986.
122. Carroll, K. K., and Khor, H. T. Effects of level and type of dietary fat on incidence of mammary tumours induced in female Sprague-Dawley rats by 7, 12-dimethylbenz(a)anthracene. Lipids, 6: 415-420, 1971.
123. Ip, C., and Ip, M. M. Serum estrogens and estrogen responsiveness in 7, 12-dimethylbenz(a)anthracene-induced mammary tumors as influenced by dietary fat. J. Natl. Cancer Inst., 66: 291-295, 1981.
124. Armstrong B., and Doll, R. Environmental factors and cancer incidence and mortality in different countries with special reference to dietary practices. Int. J. Cancer, 15: 617-631, 1975.
125. Buell, P. Changing incidence of breast cancer in Japanese-American women. J. Natl. Cancer Inst., 51: 1479-1483, 1973.
126. Miller, A. B. Role of nutrition in the etiology of breast cancer. Cancer (Phila.), 39: 2704-2708, 1977.
127. Wynder, E. L., MacCornack, F., Hill, P., Cohen, L. A., Chan, P. C., and Weisburger, J. H. Nutrition and the etiology and prevention of breast cancer. Cancer Detect. Prev., 1: 293-310, 1976.
128. Miller, A. B., Kelly, A., Choi, N. W., Matthews, V., Morgan, R. W., Munan, L., Burch, J. D., Feather, I., Howe, G. R., and Jain, M. A study of diet and breast cancer. Am. J. Epidemiol., 107: 499-509, 1978.
129. Hirayama, T. Epidemiology of breast cancer with special reference to the role of diet. Prev. Med., 7: 173-195, 1978.
130. Graham, S., Marshall, J., Mettlin, C. Rzepka, T., Nemoto, T., and Byers, T. Diet in the epidemiology of breast cancer. Am. J. Epidemiol., 116: 68-75, 1982.
131. Hiatt, R. A., Friedman, G. D., Bawol, R. D., and Dry, H. K. Breast cancer and serum cholesterol. J. Natl. Cancer Inst., 68: 885-889, 1982.
132. Phillips, R. L., and Snowdon, D. A. Association of meat and coffee use with cancers of the large bowel, breast, and prostate among Seventh-Day Adventists: Preliminary results. Cancer Res. 43 (Suppl.): 2403-2408, 1983.
133. Katsouyanni, K., Trichopoulos, D., Boyle, P., Xirouchaki, E., Trichopoulou, A., Lisseos, B., Vasilaros, S., and MacMahon, B. Diet and breast cancer: A case-control study in Greece. Int. J. Cancer, 38: 815-820, 1986.
134. Lubin, F., Wax, Y., and Modan, B. Role of fat, animal protein, and dietary fiber in breast cancer etiology: A case-control study. J. Natl. Cancer Inst., 77: 605-612, 1986.
135. Wynder, E. L., Rose, D. P., and Cohen, L. A. Diet and breast cancer in causation and therapy. Cancer (Phila.), 58 (Suppl.): 1804-1813, 1986.
136. Hirohata, T., Nomura, A. M. Y., Hankin, J. H., Kolonel, L. N., and Lee, J. An epidemiologie study on the association between diet and breast cancer. J. Natl. Cancer Inst., 78: 595-600, 1987.
137. Jones, D. Y., Schatzkin, A., Green, S. B., Block, G., Brinton, L. A., Ziegler, R. G., Hoover, R., and Taylor, P. R. Dietary fat and breast cancer in the National Health and Nutrition Examination Study I Epidemiologie Follow up Study. J. Natl. Cancer Inst., 79: 465-471, 1987.
138. Willet, W. C., Stampfer, M. J., Colditz, G. A., Rosner, B. A., Hennekens, C. H., and Speizer, F. E. Dietary fat and the risk of breast cancer. N. Engl. J. Med., 316: 22-28, 1987.
139. Kinlen, L. J. Meat and fat consumption and cancer mortality: A study of strict religious orders in Britain. Lancet, 1: 946-949, 1982.
140. Hill, P., and Wynder, E. L. Diet and prolactin release. Lancet, 2: 806-807, 1976.
141. Hill, P., Garbaczewski, L., Helman, P., Huskisson, J., Sporangisa, E., and Wynder, E. L. Diet, lifestyle, and menstrual activity. Am. J. Clin. Nutr., 33: 1192-1198, 1980.
142. Gray, G. E., Pike, M. C., and Henderson, B. E. Dietary fat and plasma prolactin. Am. J. Clin. Nutr., 34: 1160-1162, 1981.
143. Goldin, B. R., Adlercreutz, H., Gorbach, S. L., Warram, J. H., Dwyer, J. L., Swenson, L., and Woods, M. N. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N. Engl. J. Med., 307: 1542-1547, 1982.
144. Rose, D. P., Boyar, A. P., Cohen, C., and Strong, L. E. Effect of a low-fat diet on hormone levels in women with cystic breast disease I. Serum steroids and gonadotropins. J. Natl. Cancer Inst., 78: 623-626, 1987.
145. Rose, D. P., Cohen, L. A., Berke, B., and Boyar, A. P. Effect of a low-fat diet on hormone levels in women with cystic breast disease. II. Serum radioimmunoassayable prolactin and growth hormone and bioactive lactogenic hormones. J. Natl. Cancer Inst., 78: 627-631, 1987.
146. Van Noord, P. A. H., Collette, H. J. A., Maas, M. J., and DeWaard, F. Selenium levels in nails of premenopausal breast cancer patients assessed prediagnostically in a cohort-nested case-referent study among women screened in the DOM Project. Int. J. Epidemiol., 16 (Suppl.): 318-322, 1987.
147. Meyer, F., and Verreault, R. Erythrocyte selenium and breast cancer risk. Am. J. Epidemici., 125: 917-919, 1987.
148. Thompson, J. H., and Becci, P. J. Selenium inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis in the rat. J. Natl. Cancer Inst., 65: 1299-1301, 1980.
149. Brinton, L. A., Williams, R. R., Hoover, R. N., Stegens, N. L., Feinleib, M., and Fraumeni, J. F., Jr. Breast cancer risk factors among screening program participants. J. Natl. Cancer Inst., 62: 37-44, 1979.
150. Fasal, E., and Paffenbarger, R. S. Oral contraceptives as related to cancer and benign lesions of the breast. J. Natl. Cancer Inst., 55: 767-773, 1975.
151. Henderson, B. E., Powell, D., Rosario, I. Keys, C., Hanisch, R., Young, M., Casagrande, J., Gerkins, V., and Pike, M. C. An epidemiologie study of breast cancer. J. Natl. Cancer Inst., 53: 609-614, 1974.
152. Wynder, E. L., MacCornack, F. A., and Stellman, S. D. The epidemiology of breast cancer in 785 United States Caucasian women. Cancer (Phila.), 41: 2341-2354, 1978.
153. Sartwell, P. E., Arthes, F. G., and Tonasela, J. A. Exogenous hormones, reproductive history, and breast cancer. J. Natl. Cancer Inst., 59: 1589-1592, 1977.
154. Vessey, M. P., Doll, R., Jones, K., McPherson, K., and Yeates, D. Anepidemiological study of oral contraceptives and breast cancer. Br. Med. J., 1: 1757-1760, 1979.
155. Ory, H., Cole, P., MacMahon, B., and Hoover, R. Oral contraceptives and reduced risk of benign breast diseases. N. Engl. J. Med., 294: 419-422, 1976.
156. Ravnihar, B., Seigel, D. G., and Lindtner, J. An epidemiologie study of breast cancer and benign breast neoplasias in relation to the oral contraceptive and estrogen use. Eur. J. Cancer, 15: 395-405, 1979.
157. Vessey, M. P., Doll, R., and Sutton, P. M. Oral contraceptives and breast neoplasia: A retrospective study. Br. Med. J., 3: 719-724, 1972.
158. Boston Collaborative Drug Surveillance Program. Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Lancet, 1: 1399-1404, 1973.
159. Kelsey, J. L., Holford, T. R., White, C., Mayer, E. S., Kilty, S. E., and Acheson, R. M. Oral contraceptives and breast disease: An epidemiological study. Am. J. Epidemiol., 107: 236-244, 1978.
160. Lees, A. W., Burns, P. E., and Grace, M. Oral contraceptives and breast disease in premenopausal Northern Albertan women. Int. J. Cancer, 22: 700-707, 1978.
161. Royal College of General Practitioners. Breast cancer and oral contraceptives: Findings in Royal College of General Practitioners' study. Br. Med. J., 282: 2089-2093, 1981.
162. Janerich, D. T., Polednak, A. P., Glebatis, D. M., and Laurence, C. D. Breast cancer and oral contraceptive use: A case-control study. J. Chronic Dis., 36: 639-646, 1983.
163. Vessey, M. P., McPherson, K., and Doll, R. Breast cancer and oral contraceptives: Findings in Oxford Family Panning Association contraceptive study. Br. Med. J., 282: 2093-2094, 1981.
164. Vessey, M., Baron, J., Doll, R., McPherson, K., and Yeates, D. Oral contraceptives and breast cancer: Final report of an epidemiological study. Br. J. Cancer. 47: 455-462, 1983.
165. Trapido, E. J. A prospective cohort study of oral contraceptives and breast cancer. J. Natl. Cancer Inst., 67: 1011-1015, 1981.
166. Jick, H., Walker, A. M., Watkins, R. N. D'Ewart, D. C., Hunter, J. R., Danford, A., Madsen, S., Dinan, B. J., and Rothman, K. J. Oral contraceptives and breast cancer. Am. J. Epidemiol., 112: 577-585, 1980.
167. Centers for Disease Control Cancer and Steroid Hormone Study. Longterm oral contraceptive use and the risk of breast cancer. JAMA, 249: 1591-1595, 1983.
168. Lipnick, R. J., Buring, J. E., Hennekens, C. H., Rosner, B., Willett, W. Bain, C., Stampfer, M. J., Colditz, G. A., Peto, R., and Speizer, F. E. Oral contraceptives and breast cancer. A prospective cohort study. JAMA, 255: 58-61, 1986.
169. LaVecchia, C., Decarli, A., Fasali, M., Franceschi, S., Gentile, A., Negri, E., Parazzini, F., and Tognoni, G. Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study. Br. J. Cancer, 54: 311-317, 1986.
170. Paffenbarger, R. S., Fasal, E., Simmons, M. E., and Kampert, J. B. Cancer risk as related to use of oral contraceptives during fertile years. Cancer (Phila.), 39: 1887-1891, 1977.
171. Pike, M. C., Henderson, B. E., Krailo, M. D., Duke, A., and Roy, S. Breast cancer in young women and oral contraceptives, a possible modifying effect of formulation and age at use. Lancet, 2: 926-929, 1983.
172. McPherson, K., Neil, A., Vessey, M. P., and Doll, R. Oral contraceptives and breast cancer. Lancet, 2: 1414-1415, 1983.
173. McPherson, K., Vessey, M. P., Neil, A., Doll, R., Jones, L., and Roberts, M. Early oral contraceptive use and breast cancer: Results of another casecontrol study. Br. J. Cancer 56: 653-660, 1987.
174. Olsson, H., Landin Olsson, M., Moller, T. R., Ranstram, J., and Holm, P. Oral contraceptive use and breast cancer in young women in Sweden. Lancet, 1: 748-749, 1985.
175. Rosenberg, L., Miller, D. R., Kaufman, D. W., Heimlich, S. P., Stolley, P. D., Schottenfeld, D., and Shapiro, S. Breast cancer and oral contraceptive use. Am. J. Epidemiol., 119: 167-176, 1984.
176. Stadel, B. V., Rubin, G. L., Webster, L. A., Schesselman, J. J., and Wingo, P. A. Oral contraceptives and breast cancer in young women. Lancet, 2: 970-973. 1985.
177. Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. Oral contraceptive use and the risk of breast cancer. N. Engl. J. Med., 315: 405-411, 1986.
178. Paul, C., Skegg, D. C. G., Spears, G. F. S., and Kaldor, J. M. Oral contraceptives and breast cancer: A national study. Br. Med. J., 293: 723-726. 1986.
179. McPherson, K., and Drife, J. O. The pill and breast cancer: Why the uncertainty? Br. Med. J., 293: 709-710. 1986.
180. Meirik, O., Lund, E., Adami, H.-O., Bergstrom, R., Christoffersen, T., and Bergsjo, P. Oral contraceptive use and breast cancer in young women. Lancet, 2: 650-654. 1986.
181. McPherson, K., Coope, P. A., and Vessey, M. P. Early oral contraceptive use and breast cancer: Theoretical effects of latency. J. Epidemiol. Community Health, 40: 289-294, 1986.
182. Ranstam, J., Olsson, H., and Miller, T. R. Oral contraceptive use and the risk of breast cancer. N. Engl. Med., 316: 162, 1987.
183. Anonymous. Oral contraceptives and breast cancer. Lancet, 2: 665-666, 1986.
184. Pike, M. C. Breast cancer and oral contraceptives. Lancet. 2: 1180-1181, 1985.
185. Realini, J. P. Oral contraceptive use and the risk of breast cancer. N. Engl. J. Med., 316: 163. 1987.
186. Schlesselman, J. J., and Stadel, B. V. Oral contraceptives and breast cancer. Lancet, 1: 383. 1987.
187. Ratner, H. Oral contraceptive use and the risk of breast cancer. N. Engl. J. Med., 316: 162-163, 1987.
188. Sattin, R. W., Wingo, P. A., and Lee, N. L. Oral contraceptive use and risk of breast cancer. Lancet, 1: 163-164, 1987.
189. Stadel, B. V., Rubin, G. L., Wingo, P. A., and Schesselman, J. J. Oral contraceptives and breast cancer in young women. Lancet, 1: 436, 1986.
190. Casagrande, J., Gerkins, V., Henderson, B. E., Mack, T., and Pike, M. C. Exogenous estrogen and breast cancer in women with natural menopause. J. Natl. Cancer Inst., 56: 839-841, 1976.
191. Burch, J. C., Byrd, B. F., Jr., and Vaughn, W. K. The effects of long-term estrogen on hysterectomized women. Am. J. Obstet. Gynecol., 118: 778-782, 1974.
192. Wallach, S., and Henneman, P. H. Prolonged estrogen therapy in postmenopausal women. JAMA, 171: 1637-1642, 1959.
193. Wilson, R. A. The roles of estrogen and progesterone in breast and genital cancer. JAMA, 182: 327-331, 1962.
194. Kaufman, D. W., Miller, D. R., Rosenberg, L., Helmrich, S. P., Stolley, P., Schottenfeld, D., and Shapiro, S. Noncontraceptive estrogen use and the risk of breast cancer. JAMA, 252: 63-67, 1984.
195. Hulka, B. S., Chambless, L. E., Deubner, D. C., and Wilkinson, W. E. Breast cancer and estrogen replacement therapy. Am. J. Obstet. Gynecol., 143: 638-644, 1982.
196. Buring, J. E., Hennekens, C. H., Lipnick, R. J., Willett, W., Stampfer, M. J., Rosner, B., Peto, R., and Speizer, F. E., A prospective cohort study of postmenopausal hormone use and risk of breast cancer in U.S. women. Am. J. Epidemiol., 725: 939-947, 1987.
197. Brinimi, L. A., Hoover, R. N., Szklo, M., and Fraumeni, J. F., Jr. Meno pausal estrogen use and risk of breast cancer. Cancer (Phila.), 47: 2517-2522, 1981.
198. Hoover, R., Glass, A., Finkle, W. D., Azevedo, D., and Milne, K. Conjugated estrogen and breast cancer risk in women. J. Natl. Cancer Inst., 67: 815-820, 1981.
199. Hoover, R., Gray, L. W., Sr., Cole, P., and MacMahon, B. Menopausal estrogen and breast cancer. N. Engl. J. Med., 295: 401-405, 1976.
200. Jick, H., Walker, A. M., Watkins, R. N., D'Ewart, D. C., Hunter, J. R., Danford, A., Madsen, S., Dinan, B. J., and Rothman, K. J. Replacement estrogens and breast cancer. Am. J. Epidemiol., 112: 586-594, 1980.
201. Ross, R. K., Paginini-Hill, A., Gerkins, V. R., Mack, T. M., Pfeffer, R., Arthur, M., and Henderson, B. E. A case-control study of menopausal estrogen therapy and breast cancer. JAMA, 243: 1635-1639, 1980.
202. Brinton, L. A., Hoover, R., and Fraumeni, J. F., Jr. Menopausal estrogens and breast cancer risk: An expanded case-control study. Br. J. Cancer, 54: 825-832, 1986.
203. Wingo, P. A., Layde, P. M., Lee, N. C., Rubin, G., and Ory, H. W. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. JAMA, 257: 209-215, 1987.
204. LaVecchia, C., Decarli, A., Parazzini, F., Gentile, A., Liberati, L., and Franceschi, S. Non-contraceptive estrogens and the risk of breast cancer in women. Int. J. Cancer, 38: 853-858, 1986.
205. Ernster, V. L., Wrensch, M. R., Petrakis, N. L., King, E. B., Miike, R., Murai, J., Goodson, W. H., III, and Siiteri, P. K. Benign and malignant breast disease: Initial study results of serum and breast fluid analyses of endogenous estrogens. J. Natl. Cancer Inst., 79: 949-960, 1987.
206. Petrakis, N. L., Wrensch, M. R., Ernster, V. L., Miike, R., Murai, J., Similori;. N., and Siiteri, P. K. Influence of pregnancy and lactation on serum and breast fluid estrogen levels: Implications for breast cancer risk. Int. J. Cancer. 40: 587-591, 1987.
207. Stanford, J. L., Szklo, M., and Brinton, L. A. Estrogen receptors and breast cancer. Epidemiol. Rev., 8: 42-59, 1986.
208. McTiernan, A., Thomas, D. B., Johnson, L. K., and Roseman, D. Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancer. J. Natl. Cancer Inst., 77: 849-854, 1986.
209. Ballard-Barbash, R., Griffin, M. R., Fisher, L. D., Covalciuc, M. A., and Nai-Siang, J. Estrogen receptors in breast cancer: Association with epidemiological risk factors. Am. J. Epidemiol., 124: 77-84, 1986.
210. Stanford, J. L., Szklo, M., Boring, C. C., Brinton, L. A., Diamond, E. E., Greenberg, R. S., and Hoover, R. N. A case-control study of breast cancer stratified by estrogen receptor status. Am. J. Epidemiol., 725: 184-194, 1987.
211. Hislop, T. G., Coldman, A. J., Elwood, J. M., Skippen, D. H., and Kan, L. Relationship between risk factors for breast cancer and hormonal status. Int. J. Epidemiol., 15: 469-476, 1986.
212. Hildreth, N. G., Kelsey, J. L., Eisenfeld, A. J., LiVolsi, V. A., Holford, T. R., and Fischer, D. B. Differences in breast cancer risk factors according to the estrogen receptor level of the tumor. J. Natl. Cancer Inst., 70: 1027-1031, 1983.
213. Lesser, M. L., Rosen, P. P., Senie, R. T., Duthie, K., Menendez-Botet, C., and Schwartz, M. K. Estrogen and progesterone receptors in breast carcinoma: Correlations with epidemiology and pathology. Cancer (Phila.), 48: 299-309, 1981.
214. Wallace, R. B., Sherman, B. M., and Bean, J. A. Relationship between artificial menopause, previous estrogen consumption, and estrogen-receptor content of breast neoplasms-preliminary communication. Oncology (Basel), 37: 111-113, 1980.